Taizhou, China

Qixian Zhou

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qixian Zhou. Retrieved from https://idiyas.com/inventor/qixian-zhou-lpvlduea

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qixian Zhou: Innovator in Anticancer Research

Introduction

Qixian Zhou is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer medications. His innovative work has the potential to impact cancer treatment positively.

Latest Patents

Qixian Zhou holds a patent for a benzamide derivative with anticancer activity. This patent includes a preparation method and its use in creating medicines for treating cancer. The compound is described in detail, including the group definitions of the formula provided in the patent documentation.

Career Highlights

Qixian Zhou is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in cancer therapeutics. His work reflects a commitment to improving patient outcomes through innovative drug development.

Collaborations

Some of his notable coworkers include Hua Bai and Xuyang Zhao. Their collaborative efforts contribute to the ongoing research and development initiatives at their company.

Conclusion

Qixian Zhou's contributions to anticancer research exemplify the vital role of inventors in the pharmaceutical industry. His innovative approach and dedication to improving cancer treatment highlight the importance of continued research in this critical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…